Source:http://linkedlifedata.com/resource/pubmed/id/10671759
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-6-1
|
pubmed:abstractText |
The ergosterol-depleting antifungal fluconazole, when given at concentrations not affecting growth, inhibited pseudohyphal growth in Saccharomyces cerevisiae, a genetically tractable fungus closely related to the human pathogen Candida albicans. These results suggest that S. cerevisiae could serve as a useful genetic system to study the morphogenetic effects induced by azoles in pathogenic yeast.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0009-3157
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2000 S. Karger AG, Basel.
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
100-3
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading | |
pubmed:articleTitle |
Fluconazole inhibits pseudohyphal growth in Saccharomyces cerevisiae.
|
pubmed:affiliation |
Section of Infectious Diseases, Department of Internal Medicine Specialties, The University of Texas M.D. Anderson Cancer Center, Houston, Tex., USA. dkontoyi@notes.mdacc.tmc.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|